Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
156.3 USD | -6.91% | -8.36% | -13.10% |
21/05 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
14/05 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.10% | 17.56B | |
+10.56% | 115B | |
+11.74% | 106B | |
-6.08% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-40.50% | 17.32B | |
+6.08% | 14.03B | |
+31.33% | 12.13B | |
-33.77% | 7.77B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : Russia Approves BeiGene's Cancer Medicine for Treatment of Mantle Cell Lymphoma